MA29730B1 - Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant - Google Patents
Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondantInfo
- Publication number
- MA29730B1 MA29730B1 MA30617A MA30617A MA29730B1 MA 29730 B1 MA29730 B1 MA 29730B1 MA 30617 A MA30617 A MA 30617A MA 30617 A MA30617 A MA 30617A MA 29730 B1 MA29730 B1 MA 29730B1
- Authority
- MA
- Morocco
- Prior art keywords
- target antigen
- therapeutic antibody
- absence
- detection
- therapeutic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Abstract
LA PRÉSENTE INVENTION CONCERNE LES ANTICORPS THÉRAPEUTIQUES. L'INVENTION CONCERNE EN PARTICULIER UNE MÉTHODE DE DÉTECTION DE L'ANTIGÈNE CIBLE D'UN ANTICORPS THÉRAPEUTIQUE DANS UN ÉCHANTILLON, CONSISTANT A) À OBTENIR L'ÉCHANTILLON À ANALYSER, B) À INCUBER LEDIT ÉCHANTILLON AVEC L'ANTICORPS THÉRAPEUTIQUE DANS DES CONDITIONS ADAPTÉES POUR LA LIAISON DE L'ANTICORPS THÉRAPEUTIQUE À L'ANTIGÈNE CIBLE, UN COMPLEXE ANTIGÈNE CIBLE-ANTICORPS THÉRAPEUTIQUE ÉTANT AINSI FORMÉ, ET C) À DÉTECTER LE COMPLEXE FORMÉ AU COURS DE L'ÉTAPE (B).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05014618 | 2005-07-06 | ||
EP06004447 | 2006-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29730B1 true MA29730B1 (fr) | 2008-09-01 |
Family
ID=36922121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30617A MA29730B1 (fr) | 2005-07-06 | 2008-02-01 | Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070009976A1 (fr) |
EP (2) | EP1902315A1 (fr) |
JP (1) | JP2008545145A (fr) |
KR (1) | KR20080016939A (fr) |
AR (1) | AR053948A1 (fr) |
AU (1) | AU2006265275A1 (fr) |
BR (1) | BRPI0612591A2 (fr) |
CA (1) | CA2613187A1 (fr) |
CR (1) | CR9635A (fr) |
EC (1) | ECSP088081A (fr) |
IL (1) | IL188317A0 (fr) |
MA (1) | MA29730B1 (fr) |
MX (1) | MX2008000277A (fr) |
MY (1) | MY157955A (fr) |
NO (1) | NO20076662L (fr) |
NZ (1) | NZ564471A (fr) |
RU (1) | RU2008103608A (fr) |
TW (1) | TWI312864B (fr) |
WO (1) | WO2007003420A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030007640A (ko) | 2000-05-19 | 2003-01-23 | 제넨테크, 인크. | ErbB 길항제에 의한 암 치료요법에 대한 효과적인반응의 가능성을 개선시키기 위한 유전자 검출 분석 |
BRPI0513681A (pt) * | 2004-07-22 | 2008-05-13 | Genentech Inc | composição que compreendem anticorpo her2, método, formulações farmacêuticas, polipeptìdeo, anticorpo e método de tratamento de cáncer |
WO2006039486A2 (fr) | 2004-10-01 | 2006-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Agencements d'imagerie et procedes associes |
JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
RU2404806C2 (ru) | 2005-02-23 | 2010-11-27 | Дженентек, Инк. | Продление времени до прогрессирования заболевания или продолжительности жизни у онкологических больных с применением ингибиторов димеризации her |
PE20070207A1 (es) * | 2005-07-22 | 2007-03-09 | Genentech Inc | Tratamiento combinado de los tumores que expresan el her |
US8248515B2 (en) | 2006-02-07 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Variable imaging arrangements and methods therefor |
US8358354B2 (en) | 2009-01-26 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical abberations |
CL2008000614A1 (es) | 2007-03-02 | 2008-09-05 | Genentech Inc F Hoffmann La Ro | Metodo para tratar un paciente con un tipo de cancer que expresa el receptor her3 a un nivel bajo mediante la administracion de un inhibidor de la dimerizacion de her. |
TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至her2結構域ii之抗體及其酸性變異體的組合物 |
BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
CN117018187A (zh) | 2011-10-14 | 2023-11-10 | 霍夫曼-拉罗奇有限公司 | Her2二聚化抑制剂帕妥珠单抗的用途和包含her2二聚化抑制剂帕妥珠单抗的制品 |
KR101327542B1 (ko) * | 2012-03-15 | 2013-11-08 | 광주과학기술원 | 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법 |
AU2012232949B2 (en) * | 2012-09-28 | 2014-07-03 | Willowtree Holdings Pty Ltd | Temporary bulkhead |
BR112015024926A2 (pt) | 2013-04-16 | 2017-10-10 | Genentech Inc | composições, artigo de fabricação, métodos para tratar um paciente com câncer, para avaliar uma composição, para avaliar a atividade biológica, para produzir uma composição e para avaliar a fragmentação de uma composição e variante de pertuzumabe |
CN106163558A (zh) | 2014-04-25 | 2016-11-23 | 豪夫迈·罗氏有限公司 | 用曲妥珠单抗‑mcc‑dm1和帕妥珠单抗治疗早期乳腺癌的方法 |
WO2016196373A2 (fr) | 2015-05-30 | 2016-12-08 | Genentech, Inc. | Procédés de traitement de cancer du sein métastatique her2 positif |
WO2017087280A1 (fr) | 2015-11-16 | 2017-05-26 | Genentech, Inc. | Procédés de traitement d'un cancer positif her2 |
CA3046092A1 (fr) | 2016-12-28 | 2018-07-05 | Genentech, Inc. | Traitement du cancer exprimant her2 avance |
KR20200113292A (ko) | 2017-01-17 | 2020-10-06 | 제넨테크, 인크. | 피하 her2 항체 제형 |
US11077189B2 (en) | 2017-03-02 | 2021-08-03 | Genentech Inc. | Adjuvant treatment of HER2-positive breast cancer |
CN110536969A (zh) | 2017-04-24 | 2019-12-03 | 豪夫迈·罗氏有限公司 | 跨膜或近膜域中的erbb2/her2突变 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
ATE255131T1 (de) * | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
AU4025193A (en) | 1992-04-08 | 1993-11-18 | Cetus Oncology Corporation | Humanized C-erbB-2 specific antibodies |
IL129354A0 (en) | 1996-10-18 | 2000-02-17 | Genentech Inc | Anti-ErbB2 antibodies |
EP2131198B1 (fr) | 2001-09-20 | 2013-03-27 | Board of Regents, The University of Texas System | Mesure des anticorps thérapeutiques, des antigènes et des complexes antigène/anticorps circulants à l'aide d'analyse ELISA |
PT1585966E (pt) * | 2002-07-15 | 2012-02-20 | Hoffmann La Roche | Tratamento de cancro com o anticorpo anti-erbb2 rhumab 2c4 |
-
2006
- 2006-06-29 MY MYPI20063118A patent/MY157955A/en unknown
- 2006-06-29 US US11/477,772 patent/US20070009976A1/en not_active Abandoned
- 2006-07-04 AR ARP060102872A patent/AR053948A1/es not_active Application Discontinuation
- 2006-07-04 TW TW095124248A patent/TWI312864B/zh active
- 2006-07-05 WO PCT/EP2006/006524 patent/WO2007003420A1/fr active Application Filing
- 2006-07-05 CA CA002613187A patent/CA2613187A1/fr not_active Abandoned
- 2006-07-05 MX MX2008000277A patent/MX2008000277A/es not_active Application Discontinuation
- 2006-07-05 KR KR1020087000259A patent/KR20080016939A/ko active Search and Examination
- 2006-07-05 BR BRPI0612591-3A patent/BRPI0612591A2/pt not_active IP Right Cessation
- 2006-07-05 JP JP2008519853A patent/JP2008545145A/ja active Pending
- 2006-07-05 EP EP06754671A patent/EP1902315A1/fr not_active Withdrawn
- 2006-07-05 NZ NZ564471A patent/NZ564471A/en unknown
- 2006-07-05 RU RU2008103608/15A patent/RU2008103608A/ru unknown
- 2006-07-05 AU AU2006265275A patent/AU2006265275A1/en not_active Abandoned
- 2006-07-05 EP EP10157725A patent/EP2194380A3/fr not_active Withdrawn
-
2007
- 2007-12-20 IL IL188317A patent/IL188317A0/en unknown
- 2007-12-21 CR CR9635A patent/CR9635A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076662A patent/NO20076662L/no not_active Application Discontinuation
-
2008
- 2008-01-04 EC EC2008008081A patent/ECSP088081A/es unknown
- 2008-02-01 MA MA30617A patent/MA29730B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006265275A1 (en) | 2007-01-11 |
RU2008103608A (ru) | 2009-08-20 |
NO20076662L (no) | 2008-04-03 |
EP2194380A3 (fr) | 2010-07-14 |
EP1902315A1 (fr) | 2008-03-26 |
KR20080016939A (ko) | 2008-02-22 |
CR9635A (es) | 2008-02-20 |
IL188317A0 (en) | 2008-04-13 |
JP2008545145A (ja) | 2008-12-11 |
MX2008000277A (es) | 2008-03-24 |
US20070009976A1 (en) | 2007-01-11 |
BRPI0612591A2 (pt) | 2010-11-23 |
EP2194380A2 (fr) | 2010-06-09 |
NZ564471A (en) | 2010-04-30 |
TWI312864B (en) | 2009-08-01 |
TW200741203A (en) | 2007-11-01 |
WO2007003420A1 (fr) | 2007-01-11 |
AR053948A1 (es) | 2007-05-23 |
ECSP088081A (es) | 2008-02-20 |
CA2613187A1 (fr) | 2007-01-11 |
MY157955A (en) | 2016-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29730B1 (fr) | Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant | |
ATE411525T1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
FR2917174B1 (fr) | Analyse multiple d'echantillons sanguins | |
MX2009009448A (es) | Sensibilidad mejorada de determinacion de perfil de anticuerpos a traves de una colocacion en capas incrementada de anticuerpo reportero. | |
EP1381864A4 (fr) | Detection du candida | |
DE60219207D1 (de) | Diagnostisches testverfahren | |
DE602005013225D1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
NO20083820L (no) | Deteksjon av kreft ved forhoyede nivaer av BCL-2 | |
WO2010107654A3 (fr) | Dispositif à flux divisé pour analyses de partenaires à liaison spécifique | |
WO2005066612A3 (fr) | Detection de biomolecules au moyen de biodetecteurs poreux et spectroscopie raman | |
DE60300339D1 (de) | Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben | |
WO2007005666A3 (fr) | Systeme et methode de detection d'analytes au moyen de recepteurs differentiels | |
NO20052161D0 (no) | Analysemetode for hjerte-karsykdom | |
BRPI0519354B8 (pt) | método para detecção de um anticorpo terapêutico e uso de um anticorpo | |
WO2007024735A3 (fr) | Methode et anticorps destines a detecter le nitrofurane | |
WO2007063326A3 (fr) | Dispositif et procede de dosage | |
ATE537271T1 (de) | Toll-like-rezeptor-4-dysfunktion und biologische anwendungen davon | |
WO2006004958A3 (fr) | Detection ou mesure d'anticorps par rapport a proteines antigenes dans des tissus ou des echantillons biologiques | |
SG157244A1 (en) | Point of care test for the detection of exposure or immunity to dengue virus | |
RU2008129048A (ru) | Устройство с трансдермальными датчиками аналитов и способы его применения | |
WO2002099381A3 (fr) | Biocapteur monocellulaire destine a la mesure de ligands gpcr dans un echantillon pour essai | |
WO2004084841A3 (fr) | Nouveaux anticorps d'albumine anti-feline et procedes de detection de maladies renales precoces | |
NO20016080L (no) | Analyse | |
WO2006116167A8 (fr) | Procede de determination de la proteine glycoproteine ibalpha (gpibalpha) |